| Primary |
| Multiple Myeloma |
22.4% |
| Mantle Cell Lymphoma |
17.1% |
| Diffuse Large B-cell Lymphoma |
10.0% |
| Acute Myeloid Leukaemia |
9.4% |
| B-cell Lymphoma |
4.7% |
| Neuroblastoma |
4.1% |
| Non-small Cell Lung Cancer |
4.1% |
| Acute Lymphocytic Leukaemia |
3.5% |
| Small Cell Lymphocytic Lymphoma |
3.5% |
| B-cell Lymphoma Recurrent |
2.4% |
| Chronic Lymphocytic Leukaemia |
2.4% |
| Diffuse Large B-cell Lymphoma Recurrent |
2.4% |
| Renal Cell Carcinoma |
2.4% |
| Renal Cell Carcinoma Stage Unspecified |
2.4% |
| Acute Lymphocytic Leukaemia Recurrent |
1.8% |
| Graft Versus Host Disease |
1.8% |
| Non-hodgkin's Lymphoma |
1.8% |
| Product Used For Unknown Indication |
1.8% |
| Non-hodgkin's Lymphoma Recurrent |
1.2% |
| Pharyngeal Cancer Recurrent |
1.2% |
|
| Vomiting |
21.0% |
| Thrombocytopenia |
12.9% |
| Pyrexia |
9.7% |
| Herpes Zoster |
4.8% |
| Nausea |
4.8% |
| Streptococcus Test Positive |
4.8% |
| Diarrhoea |
3.2% |
| Neuropathy Peripheral |
3.2% |
| Pain In Extremity |
3.2% |
| Peripheral Sensorimotor Neuropathy |
3.2% |
| Pleural Effusion |
3.2% |
| Pseudomonal Sepsis |
3.2% |
| Respiratory Failure |
3.2% |
| Staphylococcal Infection |
3.2% |
| Syncope |
3.2% |
| Tachycardia |
3.2% |
| Unresponsive To Stimuli |
3.2% |
| White Blood Cell Count Increased |
3.2% |
| Abdominal Discomfort |
1.6% |
| Anaemia |
1.6% |
|
| Secondary |
| Multiple Myeloma |
38.9% |
| Plasma Cell Myeloma |
13.7% |
| Product Used For Unknown Indication |
11.3% |
| Prophylaxis |
5.2% |
| Drug Use For Unknown Indication |
4.5% |
| Mantle Cell Lymphoma |
4.3% |
| Acute Lymphocytic Leukaemia |
4.1% |
| Infection Prophylaxis |
2.4% |
| Non-hodgkin's Lymphoma |
2.2% |
| Pain |
2.0% |
| Diffuse Large B-cell Lymphoma |
1.9% |
| B-cell Lymphoma |
1.8% |
| Thrombosis Prophylaxis |
1.6% |
| Hypertension |
1.3% |
| Acute Myeloid Leukaemia |
0.9% |
| Nausea |
0.8% |
| Waldenstrom's Macroglobulinaemia |
0.8% |
| Amyloidosis |
0.8% |
| Leukaemia Plasmacytic |
0.8% |
| Antiviral Prophylaxis |
0.7% |
|
| Thrombocytopenia |
16.9% |
| Neuropathy Peripheral |
9.4% |
| Vomiting |
8.1% |
| Pyrexia |
7.8% |
| Gastrointestinal Inflammation |
6.6% |
| Pneumonia |
6.0% |
| Sepsis |
5.9% |
| Febrile Neutropenia |
3.8% |
| Platelet Count Decreased |
3.5% |
| Syncope |
3.5% |
| Neutropenia |
3.4% |
| Neurotoxicity |
3.2% |
| Pulmonary Embolism |
3.1% |
| White Blood Cell Count Decreased |
3.1% |
| Nausea |
2.8% |
| Septic Shock |
2.8% |
| Bronchiolitis |
2.7% |
| Renal Failure |
2.7% |
| Lung Disorder |
2.5% |
| Death |
2.4% |
|
| Concomitant |
| Multiple Myeloma |
30.4% |
| Product Used For Unknown Indication |
18.7% |
| Plasma Cell Myeloma |
16.6% |
| Drug Use For Unknown Indication |
15.6% |
| Prophylaxis |
2.3% |
| Mantle Cell Lymphoma |
2.0% |
| Plasmacytoma |
1.8% |
| Prophylaxis Against Transplant Rejection |
1.7% |
| Thrombosis Prophylaxis |
1.6% |
| Pain |
1.5% |
| Myeloma Recurrence |
1.0% |
| Chemotherapy |
1.0% |
| Disease Progression |
0.9% |
| Metastases To Bone |
0.9% |
| Neoplasm Malignant |
0.8% |
| Pyrexia |
0.8% |
| Plasma Cell Myeloma Recurrent |
0.8% |
| Hypertension |
0.7% |
| Amyloidosis |
0.6% |
| Immunosuppression |
0.5% |
|
| Unevaluable Event |
13.4% |
| Toxicity To Various Agents |
10.0% |
| Thrombocytopenia |
9.7% |
| Vomiting |
9.4% |
| Plasma Cell Myeloma |
6.7% |
| Multiple Myeloma |
6.0% |
| Osteonecrosis |
5.7% |
| Renal Failure Acute |
4.0% |
| Pneumonia |
3.7% |
| Pulmonary Embolism |
3.7% |
| Neuropathy Peripheral |
3.3% |
| Renal Failure |
3.3% |
| Adverse Drug Reaction |
3.0% |
| Death |
2.7% |
| Purulent Discharge |
2.7% |
| Pyrexia |
2.7% |
| Tooth Extraction |
2.7% |
| Tumour Lysis Syndrome |
2.7% |
| Osteonecrosis Of Jaw |
2.3% |
| Pancytopenia |
2.3% |
|
| Interacting |
| Product Used For Unknown Indication |
37.3% |
| Multiple Myeloma |
29.4% |
| Infection Prophylaxis |
9.8% |
| Plasma Cell Myeloma |
7.8% |
| Fungal Infection |
5.9% |
| Pyrexia |
3.9% |
| Antifungal Prophylaxis |
2.0% |
| Prophylaxis |
2.0% |
| Prostatitis |
2.0% |
|
| Tubulointerstitial Nephritis |
45.5% |
| Thrombocytopenia |
27.3% |
| Ileus Paralytic |
13.6% |
| Neuropathy Peripheral |
4.5% |
| Syncope |
4.5% |
| Urinary Retention |
4.5% |
|
